By integrating AI into drug development, organizations are streamlining processes, enhancing data utilization and bringing life-saving treatments to patients faster than ever. But there are many challenges to implementing this transformative technology—and the solutions depend largely on the individual organization. In this webinar, we talk with Johnson & Johnson Innovative Medicine’s Asha Mehesh and BMS’s Dan Bachalis about how organizations are adopting AI, leadership’s role in fostering a culture of innovation and the strategic alignment between building and buying AI solutions.
 

You’ll also learn:

• Strategies for ensuring data readiness to maximize AI’s potential
• Best practices for maintaining data security and compliance
• Approaches to agentic architecture: balancing build versus buy decisions in AI strategy